Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of hepatic steatosis and fibrosis before and after chelation therapy in chronic lead poisoning
TCTR20191108001Completed
- Sponsor
- Chulalongkorn University
- Start
- Nov 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial in lead poisoning, steatosis and hepatic fibrosis, sponsored by Chulalongkorn University. Primary endpoints: Change in hepatic steatosis level and Change in hepatic fibrosis level. Started Nov 2017; status: completed.
02
Conditions
lead poisoningsteatosishepatic fibrosis
Beyond the preview
Go deeper on TCTR20191108001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191108001.